Literature DB >> 32786369

Caspase-Activated Oligonucleotide Probe.

Linlin Yang1, James H Eberwine2, Ivan J Dmochowski1.   

Abstract

Light-activated ("caged") oligonucleotides provide a strategy for modulating the activity of antisense oligos, siRNA, miRNA, aptamers, DNAzymes, and mRNA-capturing probes with high spatiotemporal resolution. However, the near-UV and visible wavelengths that promote these bond-breaking reactions poorly penetrate living tissue, which limits some biological applications. To address this issue, we describe the first example of a protease-activated oligonucleotide probe, capable of reporting on caspase-3 during cellular apoptosis. The 2'-F RNA-peptide substrate-peptide nucleic acid (PNA) hairpin structure was generated in 30% yield in a single bioconjugation step.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32786369      PMCID: PMC8319955          DOI: 10.1021/acs.bioconjchem.0c00362

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  51 in total

1.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes.

Authors:  Vsevolod V Rostovtsev; Luke G Green; Valery V Fokin; K Barry Sharpless
Journal:  Angew Chem Int Ed Engl       Date:  2002-07-15       Impact factor: 15.336

Review 2.  Enzyme responsive drug delivery systems in cancer treatment.

Authors:  Mahsa Shahriari; Mahsa Zahiri; Khalil Abnous; Seyed Mohammad Taghdisi; Mohammad Ramezani; Mona Alibolandi
Journal:  J Control Release       Date:  2019-07-08       Impact factor: 9.776

3.  Antisense Oligonucleotides Internally Labeled with Peptides Show Improved Target Recognition and Stability to Enzymatic Degradation.

Authors:  Maria Taskova; Charlotte S Madsen; Knud J Jensen; Lykke Haastrup Hansen; Birte Vester; Kira Astakhova
Journal:  Bioconjug Chem       Date:  2016-12-01       Impact factor: 4.774

4.  Sequential gene silencing using wavelength-selective caged morpholino oligonucleotides.

Authors:  Sayumi Yamazoe; Qingyang Liu; Lindsey E McQuade; Alexander Deiters; James K Chen
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-01       Impact factor: 15.336

5.  Dextran-Conjugated Caged siRNA Nanoparticles for Photochemical Regulation of RNAi-Induced Gene Silencing in Cells and Mice.

Authors:  Changmai Chen; Zhongyu Wang; Jinhao Zhang; Xinli Fan; Luzheng Xu; Xinjing Tang
Journal:  Bioconjug Chem       Date:  2019-04-24       Impact factor: 4.774

6.  Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s).

Authors:  Shinji Kamada; Ushio Kikkawa; Yoshihide Tsujimoto; Tony Hunter
Journal:  J Biol Chem       Date:  2004-11-29       Impact factor: 5.157

7.  Reprogramming Caspase-7 Specificity by Regio-Specific Mutations and Selection Provides Alternate Solutions for Substrate Recognition.

Authors:  Maureen E Hill; Derek J MacPherson; Peng Wu; Olivier Julien; James A Wells; Jeanne A Hardy
Journal:  ACS Chem Biol       Date:  2016-03-31       Impact factor: 5.100

Review 8.  Caspase substrates and inhibitors.

Authors:  Marcin Poreba; Aleksandra Strózyk; Guy S Salvesen; Marcin Drag
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

9.  Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.

Authors:  Samir E L Andaloussi; Taavi Lehto; Imre Mäger; Katri Rosenthal-Aizman; Iulian I Oprea; Oscar E Simonson; Helena Sork; Kariem Ezzat; Dana M Copolovici; Kaido Kurrikoff; Joana R Viola; Eman M Zaghloul; Rannar Sillard; Henrik J Johansson; Fatouma Said Hassane; Peter Guterstam; Julia Suhorutšenko; Pedro M D Moreno; Nikita Oskolkov; Jonas Hälldin; Ulf Tedebark; Andres Metspalu; Bernard Lebleu; Janne Lehtiö; C I Edvard Smith; Ulo Langel
Journal:  Nucleic Acids Res       Date:  2011-01-17       Impact factor: 16.971

Review 10.  Caspases: therapeutic targets in neurologic disease.

Authors:  Carol M Troy; Ying Y Jean
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 6.088

View more
  1 in total

Review 1.  Conditionally Activated ("Caged") Oligonucleotides.

Authors:  Linlin Yang; Ivan J Dmochowski
Journal:  Molecules       Date:  2021-03-09       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.